Extracorporeal shock wave lithotripsy

Extracorporeal shock wave lithotripsy
Name	Extracorporeal shock wave lithotripsy
Specialty	Urology
Invented by	Christian Chaussy; Georg Ludwig Dornier
Introduction	1980s

Extracorporeal shock wave lithotripsy is a noninvasive procedure that fragments urinary tract calculi by delivering focused acoustic pulses from outside the body. Initially developed in the late 20th century, the technique rapidly altered management paradigms in Urology and reduced the need for open surgery in favor of ambulatory care promoted by institutions like the Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital. Contemporary practice integrates equipment and protocols influenced by manufacturers and research centers associated with Dornier MedTech, Siemens, Storz Medical, Boston Scientific, and academic groups at Harvard Medical School and University of California, San Francisco.

Medical uses

Extracorporeal shock wave lithotripsy is indicated primarily for renal and ureteric calculi managed within guidelines from organizations such as the American Urological Association, European Association of Urology, and the National Institute for Health and Care Excellence. Clinical decision making often references evidence from randomized trials conducted at centers like Karolinska Institutet, University College London, and Mayo Clinic comparing outcomes against procedures favored by Society of Laparoendoscopic Surgeons and protocols used at Massachusetts General Hospital. Indications cover nephrolithiasis and proximal ureteric stones typically under size thresholds derived from studies at Johns Hopkins Hospital, University of Oxford, and University of Toronto, while alternatives such as ureteroscopy and percutaneous nephrolithotomy are considered in guidelines from the European Association of Urology and the American Urological Association.

Procedure

The procedure is performed in ambulatory suites modeled after workflow standards at Cleveland Clinic and Mount Sinai Health System. Patients are positioned on a treatment table developed by manufacturers like Dornier MedTech and monitored using imaging modalities produced by Siemens and GE Healthcare; intraoperative imaging options include fluoroscopy employed in protocols from Memorial Sloan Kettering Cancer Center and ultrasound techniques described by investigators at Mayo Clinic and Stanford University. Analgesia strategies follow recommendations from anesthesiology departments at Johns Hopkins Hospital and Royal College of Anaesthetists, ranging from sedation regimens used at Guy's and St Thomas' NHS Foundation Trust to regional blocks taught at Karolinska Institutet. Postprocedure care aligns with discharge pathways promoted by NHS England and quality improvement programs at American College of Surgeons.

Mechanism and technology

Shock wave generators trace lineage to engineering programs at Dornier GmbH and physics research at University of Munich; device classes include electrohydraulic systems commercialized by Dornier MedTech, electromagnetic units developed by Siemens and Storz Medical, and piezoelectric arrays researched at Massachusetts Institute of Technology. Biophysical models cited in papers from Harvard Medical School, University of Cambridge, and ETH Zurich explain stone fragmentation through tensile and compressive stresses, cavitation processes investigated in laboratories at California Institute of Technology and Max Planck Society, and acoustic focusing principles refined with computational work from Stanford University and Imperial College London. Imaging integration with systems from GE Healthcare and Philips facilitates targeting protocols validated by multicenter trials coordinated by groups at University of Toronto and University of Pennsylvania.

Outcomes and complications

Clinical outcomes are reported in registries maintained by organizations such as the American Urological Association and cohort studies from Mayo Clinic, Cleveland Clinic, and Karolinska Institutet. Success rates vary with stone size and composition as characterized by spectroscopic analyses from Massachusetts General Hospital and composition registries at Johns Hopkins Hospital. Complications documented in case series from University College London and University of Oxford include hematuria, renal colic, perirenal hematoma, and rare reports of hypertension and renal impairment; management algorithms mirror practices at Mount Sinai Health System and recommendations promulgated by European Association of Urology. Long-term follow-up studies from Duke University and University of California, San Francisco assess recurrence risk and metabolic evaluation strategies aligned with guidance from the American Urological Association.

Contraindications and patient selection

Contraindications and selection criteria reflect consensus statements from American Urological Association, European Association of Urology, and safety advisories from regulatory authorities including the Food and Drug Administration and the Medicines and Healthcare products Regulatory Agency. Absolute and relative contraindications cited in guidelines from Royal College of Surgeons and publications from Johns Hopkins Hospital include pregnancy, uncorrected coagulopathy as managed under protocols at Mayo Clinic, and cases where alternative therapies such as percutaneous nephrolithotomy or ureteroscopy—routinely performed at centers like Cleveland Clinic and Massachusetts General Hospital—offer superior efficacy. Patient counseling and shared decision making draw on frameworks developed at NHS England and patient outcome research from Stanford University.

History and development

The technique originated from interdisciplinary collaborations involving engineers at Dornier GmbH and urologists in projects at University of Munich and University of Chicago, with pioneering clinical adoption in the 1980s documented by teams at University of Zürich, University of Munich, and Karolinska Institutet. Subsequent diffusion involved regulatory approvals through the Food and Drug Administration and health technology assessments by NICE that shaped adoption in health systems such as NHS England and institutions like Mayo Clinic and Massachusetts General Hospital. Ongoing innovation has come from research consortia linking Massachusetts Institute of Technology, Stanford University, ETH Zurich, and industry partners including Dornier MedTech, Siemens, and Boston Scientific, influencing training programs at Harvard Medical School and continuing medical education offered by the European Association of Urology.

Category:Urology